ESTABLISHMENT AND CHARACTERIZATION OF A NEW PH(1)-POSITIVE CHRONIC MYELOID-LEUKEMIA CELL-LINE MC3 WITH TRILINEAGE PHENOTYPE AND AN ALTERED P53 GENE

被引:13
作者
OKABE, M
KUNIEDA, Y
NAKANE, S
KUROSAWA, M
ITAYA, T
VOGLER, WR
SHOJI, M
MIYAZAKI, T
机构
[1] Third Department of Internal Medicine, Hokkaido University School of Medicine, Sapporo
[2] Section of Clinical Laboratory, Hokkaido University School of Medicine, Sapporo
[3] Department of Medicine, Section of Hematology/Oncology, Emory University School of Medicine, Atlanta, GA
关键词
PH(1)-POSITIVE CML; LEUKEMIA CELL LINE; TRILINEAGE PHENOTYPE; P53; TYPE;
D O I
10.3109/10428199509054439
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A new Ph(1)-positive leukemic cell line (MC3) expressing the P210(bcr/abl) oncoprotein was established from a patient with CML in blast crisis. The MC3 cells showed the trilineage phenotype of myeloid, lymphoid (CD19) and megakaryocytoid lineages, and had a proliferative response to rhIL-1 and rhIL-3 in the serum-free culture. These results and the expression of CD34 indicated that the MC3 cells have characteristics of hematopoietic progenitor cells. Recently, it has been documented that alterations of the p53 gene in leukemic cells are frequently detected during the blast crisis of CML. The MC3 cells contained the altered p53 gene. In addition, the original leukemic cells showed the point-mutational activation of the N-ras gene and an additional chromosomal abnormality inv(3q), but the MC3 cells contained no such abnormalities, indicating that not all of the original leukemic cells had these abnormalities. Thus, the MC3 cell line may provide several insights into investigations of the blast crisis in CML as well as hematopoietic progenitor cells.
引用
收藏
页码:493 / 503
页数:11
相关论文
共 33 条
[1]  
Heisterkamp N., Stephen J.R., Groffen J., Hanesen P.F., deKlein A., Bartrum C.R., Grosveld G., Localization of the c-abl oncogene adjacent to a translocation breakpoint in chronic myelogenous leukemia, Nature, 306, pp. 239-242, (1983)
[2]  
Groffen J., Stephenson J.R., Heisterkamp N., Deklein A., Bartram C.R., Grosveld G., Philadelphia chromosomal breakpoints are clustered within a limited region, ber, on chromosome 22, Cell, 36, pp. 93-99, (1984)
[3]  
Konopka J.B., Watanabe S.M., Witte O.N., An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity, Cell., 37, pp. 1035-1042, (1984)
[4]  
Daley G.O., Baltimore D., Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210<sup>ber/abl</sup> protein, Proc. Nail. Acad. Sci. USA, 85, pp. 9312-9316, (1988)
[5]  
Daley G.Q., Van Etten R.A., Baltimore D., Induction of chronic myelogenous leukemia in mice by the P210ber/abl gene of the Philadelphia chromosome, Science, 247, pp. 824-830, (1991)
[6]  
Pendergast A.M., Muller A.J., Havlik M.H., Maru Y., Witte O.N., BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner, Cell, 66, pp. 161-171, (1991)
[7]  
Bernstein R., Cytogenetics of chronic myelogenous leukemia, Semin. HematoL, 25, pp. 20-34, (1988)
[8]  
Collins S.J., Groudine M.T., Chronic myelogenous leukemia: Amplification of a rearranged c-abl oncogene in both chronic phase and blast crisis, Blood, 69, pp. 893-898, (1987)
[9]  
Okabe M., Matsushima S., Philadelphia chromosome-positive leukemia: Molecular analysis of ber and abl genes and transforming genes, Acta Haematol. Japonica, 51, pp. 1471-1480, (1988)
[10]  
Liu E., Hjelle B., Bishop J.M., Transforming genes in chronic myelogenous leukemia, Proc. Natl. Acad. Sci. USA, 85, pp. 1952-1956, (1988)